Liaoning Historical Income Statement
| 688739 Stock | 25.90 0.35 1.37% |
Historical analysis of Liaoning Chengda income statement accounts such as Net Interest Income of 84.4 M, Interest Income of 86.7 M or Selling General Administrative of 365.2 M can show how well Liaoning Chengda Biotechnology performed in making a profits. Evaluating Liaoning Chengda income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Liaoning Chengda's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Liaoning Chengda Bio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Liaoning Chengda Bio is a good buy for the upcoming year.
Liaoning |
About Liaoning Income Statement Analysis
Liaoning Chengda Bio Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Liaoning Chengda shareholders. The income statement also shows Liaoning investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Liaoning Chengda Income Statement Chart
Tax Provision
The amount set aside by a company to cover any estimated taxes for the current period. It reflects the company's expected tax liabilities.Total Revenue
Total revenue comprises all receipts Liaoning Chengda Bio generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Gross Profit
Gross profit is a required income statement account that reflects total revenue of Liaoning Chengda Biotechnology minus its cost of goods sold. It is profit before Liaoning Chengda operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.Most accounts from Liaoning Chengda's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Liaoning Chengda Bio current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Liaoning Chengda Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. At present, Liaoning Chengda's Tax Provision is projected to decrease significantly based on the last few years of reporting. The current year's Net Interest Income is expected to grow to about 84.4 M, whereas Selling General Administrative is forecasted to decline to about 365.2 M.
| 2022 | 2023 | 2024 | 2025 (projected) | Net Interest Income | 55.6M | 69.9M | 80.3M | 84.4M | Tax Provision | 124.1M | 110.5M | 99.4M | 102.7M |
Liaoning Chengda income statement Correlations
Click cells to compare fundamentals
Liaoning Chengda Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Liaoning Chengda income statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Tax Provision | 144.7M | 138.5M | 124.1M | 110.5M | 99.4M | 102.7M | |
| Net Interest Income | 3.9M | 4.1M | 55.6M | 69.9M | 80.3M | 84.4M | |
| Interest Income | 4.6M | 6.1M | 57.4M | 71.8M | 82.6M | 86.7M | |
| Selling General Administrative | 232.3M | 363.6M | 337.7M | 368.1M | 423.3M | 365.2M | |
| Total Revenue | 2.0B | 2.1B | 1.8B | 1.8B | 1.6B | 1.5B | |
| Gross Profit | 1.7B | 1.9B | 1.6B | 1.5B | 1.3B | 1.3B | |
| Operating Income | 987.8M | 1.0B | 778.4M | 592.7M | 533.5M | 667.8M | |
| Net Income From Continuing Ops | 918.2M | 892.5M | 714.0M | 465.9M | 419.3M | 590.2M | |
| Research Development | 222.4M | 237.7M | 211.5M | 220.5M | 253.5M | 230.0M | |
| Cost Of Revenue | 274.3M | 211.9M | 233.9M | 286.2M | 329.1M | 274.2M | |
| Total Operating Expenses | 1.0B | 1.1B | 1.0B | 1.2B | 1.3B | 1.1B | |
| Reconciled Depreciation | 64.8M | 116.1M | 121.2M | 125.3M | 144.1M | 109.0M | |
| Income Before Tax | 1.1B | 1.0B | 838.1M | 576.4M | 518.7M | 692.9M | |
| Net Income | 918.2M | 892.5M | 714.0M | 465.9M | 419.3M | 590.2M |
Currently Active Assets on Macroaxis
| EBR | Centrais Electricas Brasileiras | |
| HE | Hawaiian Electric Industries | |
| VFC | VF Corporation | |
| BVHMF | Vistry Group PLC | |
| S | SentinelOne |
Other Information on Investing in Liaoning Stock
Liaoning Chengda Bio Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Liaoning Chengda shareholders. The income statement also shows Liaoning investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).